The number of people living with type 1 diabetes worldwide is projected to jump nearly 30% over the next two decades from 9.4 million today to 12.1 million by 2049.
The weight loss drug Zepbound might cut the risk of heart attack or stroke among type 2 diabetics with excess weight and heart problems, a new study says.
